CANNON JAMES ANTHONY 4
4 · ZIOPHARM ONCOLOGY INC · Filed May 8, 2019
Insider Transaction Report
Form 4
CANNON JAMES ANTHONY
Director
Transactions
- Exercise/Conversion
Common Stock
2019-05-07$0.70/sh+15,000$10,500→ 398,050 total - Exercise/Conversion
Stock Option (right to buy)
2019-05-07−15,000→ 0 totalExercise: $0.70Exp: 2019-05-13→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]Fully vested.